MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0019088
Trimark Pharmaceuticals Private Limited - trading in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹91.65 Lakh
▲ 7% YoY
Net profit · FY 2024
₹64,414
Net margin 0.7%
EBITDA · FY 2024
₹88,299
EBITDA margin 1%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Trimark Pharmaceuticals Private Limited
Data last updated:
Trimark Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 09 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2016PTC112866. Its GSTIN is 36AAFCT9866K1ZI (Telangana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Rajendraprasad Kasarapu and Pranitha Kasarapu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹91.65 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹64,414 (net margin 0.7%) and EBITDA of ₹88,299 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 457% over three years and 26% over five years.
The company is associated with 1 brand: Trimark.
Trimark Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0019088). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website trimarkpharma.com.
Company details
CIN U74999TG2016PTC112866
Registration Number 112866
Incorporation Date 09 November 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0019088
Recognitions & Rankings of Trimark Pharmaceuticals
Contact details
Trimark Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is trimarkpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 17 Survey Nos. 15 & 33 New City Colony Sanjeevaiah Bapuji Nagar Bowenpally Se, Cunderabad, Hyderabad, Telangana, India – 500009
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Trimark Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Trimark Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Trimark Pharmaceuticals operates one associated brand: Trimark. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company focused on supplying innovative healthcare products and services globally. | trimarkpharma.com |
Business activity
The main business activity of Trimark Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Trimark Pharmaceuticals Private Limited, buy the company report.
Financials of Trimark Pharmaceuticals Private Limited
FY 2025 filings availableTrimark Pharmaceuticals Private Limited reported revenue of ₹91.65 Lakh (up 7% YoY) for FY 2024.
Revenue · FY 2024
₹91.65 Lakh ▲ 7%
Net profit · FY 2024
₹64,414 margin 0.7%
EBITDA · FY 2024
₹88,299 margin 1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 457%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 314%
5 years · compounded
▲ 14%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 7% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹88,299 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹64,414 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Trimark Pharmaceuticals Private Limited, buy the company report.
Board of directors of Trimark Pharmaceuticals Private Limited
Trimark Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendraprasad Kasarapu | Director | 09 Nov 2016 | 9 Years 11 Months | Current |
| Pranitha Kasarapu | Director | 09 Nov 2016 | 9 Years 11 Months | Current |
| Uday Kumar Akula | Director | 06 Apr 2023 | 3 Years 6 Months | Current |
| Pavan Kumar Dubba | Director | 06 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Trimark Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Redblue Life Sciences Private Limited | ₹91.8 Lakh (FY 2021) | 38.0% | Kanpur, Uttar Pradesh, India | |||
| Bradina Aaronalis Pharmaceuticals Private Limited | ₹91.78 Lakh (FY 2024) | -19.0% | Ludhiana, Punjab, India | |||
| Duta Formulations Private Limited | ₹91.76 Lakh (FY 2023) | 38.0% | Bangalore, Karnataka, India | |||
| Trimark Pharmaceuticals Private Limitedthis company | ₹91.65 Lakh (FY 2024) | ₹64,414 | 0.7% | 7.0% | Hyderabad, Telangana, India | |
| Saaggifo Chemicals and Pharmaceuticals Private Limited | ₹91.27 Lakh (FY 2019) | -5.0% | Kolkata, West Bengal, India | |||
| Ir Pharmaceuticals Private Limited | ₹90.86 Lakh (FY 2024) | 41.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Trimark Pharmaceuticals Private Limited, buy the company report.
Auditor
Trimark Pharmaceuticals Private Limited is audited by RAJGOLLAPPAGARI for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJGOLLAPPAGARI | FY 2017 | 219531 |
Shareholding
The shareholding of Trimark Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Trimark Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Trimark Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trimark Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Trimark Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCT9866K1ZI | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Trimark Pharmaceuticals Private Limited, buy the company report.
Recent activity
Trimark Pharmaceuticals Private Limited has 8 board changes on record since 2016: 4 appointments and 4 cessations. The latest: Vidhyulatha Basireddy ceased to be Director on 18 Mar 2024.
AGM
Trimark Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Trimark Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Vidhyulatha Basireddy ceased to be Director.
Ceased
Pavan Kumar Dubba ceased to be Additional Director.
Ceased
Uday Kumar Akula ceased to be Additional Director.
Appointed
Pavan Kumar Dubba was appointed as Director.
Appointed
Uday Kumar Akula was appointed as Director.
Ceased
Sunilkumar Vallabhaneni ceased to be Director.
Appointed
Pranitha Kasarapu was appointed as Director.
Appointed
Rajendraprasad Kasarapu was appointed as Director.
Incorporation
09 Nov 2016
Trimark Pharmaceuticals Private Limited was registered on 09 Nov 2016 with Roc Hyderabad & aged 9 years 11 months as per MCA records.
Frequently asked questions
Trimark Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in wholesale, within the trading industry. It was incorporated on 09 November 2016 (10+ years old) and is registered under CIN U74999TG2016PTC112866.
Trimark Pharmaceuticals has 4 current directors:
- Rajendraprasad Kasarapu - Director
- Pranitha Kasarapu - Director
- Uday Kumar Akula - Director
- Pavan Kumar Dubba - Director
The latest financial statements of Trimark Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Trimark Pharmaceuticals is 36AAFCT9866K1ZI, registered in Telangana.
The CIN (Corporate Identification Number) of Trimark Pharmaceuticals is U74999TG2016PTC112866. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trimark Pharmaceuticals was incorporated on 09 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Trimark Pharmaceuticals by revenue are Redblue Life Sciences Private Limited, Bradina Aaronalis Pharmaceuticals Private Limited, Duta Formulations Private Limited, Saaggifo Chemicals and Pharmaceuticals Private Limited, Ir Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Vidhyulatha Basireddy ceased to be Director on 18 Mar 2024. Pavan Kumar Dubba ceased to be Additional Director on 27 Aug 2023. Uday Kumar Akula ceased to be Additional Director on 27 Aug 2023. Trimark Pharmaceuticals has 8 board changes on record in total.
Yes, Trimark Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0019088).
Trimark Pharmaceuticals can be reached through the website trimarkpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Trimark Pharmaceuticals is at Plot No. 17 Survey Nos. 15 & 33 New City Colony Sanjeevaiah Bapuji Nagar Bowenpally Se, Cunderabad, Hyderabad, Telangana, India – 500009.